Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02581878
What this trial is testing

Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Bayer 21
Early research (Phase 1)Study completedNCT02864810
What this trial is testing

Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism

Who this might be right for
Thromboembolism
Asan Foundation 32
Not applicableStudy completedNCT06460467
What this trial is testing

Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry

Who this might be right for
Meningioma
Central Hospital, Nancy, France 25
Testing effectiveness (Phase 2)Looking for participantsNCT06139575
What this trial is testing

Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Bivision Pharmaceuticals, Inc. 90
Very early researchLooking for participantsNCT06688188
What this trial is testing

68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study

Who this might be right for
Malignant Neoplasm
First Affiliated Hospital of Fujian Medical University 5
Early research (Phase 1)Looking for participantsNCT07258836
What this trial is testing

[18F]LY4214835 in Healthy Volunteers and Participants With Cancer

Who this might be right for
NeoplasmsHealthy
Eli Lilly and Company 41
Not applicableStudy completedNCT05666193
What this trial is testing

On-treatment Adaptation of Head and Neck Cancer Dosimetry Plans Using Novel Cone-beam CT and AI-driven Software

Who this might be right for
Head and Neck Cancer
Varian, a Siemens Healthineers Company 30
Early research (Phase 1)Study completedNCT03822871
What this trial is testing

A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Cancer Targeted Technology 17
Not applicableStudy completedNCT00693173
What this trial is testing

Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients

Who this might be right for
Anal Cancer
The University of Texas Medical Branch, Galveston 14
Testing effectiveness (Phase 2)Study completedNCT00597129
What this trial is testing

Safety and Efficacy Study of 90Y-hPAM4 at Different Doses

Who this might be right for
Pancreatic Cancer
Gilead Sciences 21
Large-scale testing (Phase 3)Looking for participantsNCT05387603
What this trial is testing

Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.

Who this might be right for
Neuroendocrine Tumors
Lund University Hospital 300
Early research (Phase 1)Study completedNCT00712829
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents

Who this might be right for
Prostate Cancer
Molecular Insight Pharmaceuticals, Inc. 12
Early research (Phase 1)Study completedNCT06122610
What this trial is testing

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsSomatostatin Receptor-positive Neuroendocrine Tumor
University of Wisconsin, Madison 4
Testing effectiveness (Phase 2)Looking for participantsNCT04939610
What this trial is testing

177Lu-FAP-2286 in Advanced Solid Tumors

Who this might be right for
Solid Tumor
Novartis Pharmaceuticals 222
Very early researchUnknownNCT01527058
What this trial is testing

68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients

Who this might be right for
Lung Cancer
Peking Union Medical College Hospital 100
Early research (Phase 1)Study completedNCT06840548
What this trial is testing

Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)
Philogen S.p.A. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06184035
What this trial is testing

A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer

Who this might be right for
Solid TumorMetastatic CancerUnresectable Solid Tumor+3 more
Spago Nanomedical AB 90
Very early researchLooking for participantsNCT06995976
What this trial is testing

Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

Who this might be right for
Malignant Tumour
First Affiliated Hospital of Fujian Medical University 30
Testing effectiveness (Phase 2)UnknownNCT06250244
What this trial is testing

177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital 12
Early research (Phase 1)Looking for participantsNCT06562192
What this trial is testing

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerHR+/HER2- Ductal and Lobular Breast Cancer+2 more
Novartis Pharmaceuticals 162
Next Page